newstreatment resistanceschizophrenia
Angiotensin-Converting Enzyme as a Biomarker and Therapeutic Target in Early-Stage Psychosis
By MedXY|Sep 27, 2026
This study reveals significantly reduced ACE protein levels in cerebrospinal fluid and serum of early-stage psychosis patients, particularly in treatment-resistant cases, highlighting a potential biomarker and mechanistic role beyond enzyma